Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy

BACKGROUND: Although radioiodine therapy (RIT) efficacy is thoroughly validated for Graves disease (GD), there is a lack of research on the predictive factors of RIT, especially the optimal thyroid-absorbed dose (TD) with a shorter effective half-life (T(eff) ≤5 days). The goal of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Feng, Zhang, Ruiguo, Zhang, Guizhi, Meng, Zhaowei, Liu, Xiaohua, He, Yajing, Tan, Jian, Wang, Renfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847087/
https://www.ncbi.nlm.nih.gov/pubmed/33497370
http://dx.doi.org/10.12659/MSM.928796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847087/
https://www.ncbi.nlm.nih.gov/pubmed/33497370
http://dx.doi.org/10.12659/MSM.928796

Ejemplares similares